Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Take Control. Period. - Needs Assessment Leading to the Development of a Digital Quality Improvement Intervention Designed to Enhance Adherence to Tranexamic Acid and Iron Supplementation in Women with Heavy Menstrual Bleeding

Ying Ling, BMSc, MD, Filomena Meffe, MD MSc, Deborah Robertson, MD, Jessica Petrucci, MSc, Georgina Floros, RN, Paula D. James, MD, Jeffrey Mosko, MD MSc, Michelle Sholzberg, MDBSc,FRCPC,MSc

Blood (2019) 134 (Supplement_1): 5868.

https://doi.org/10.1182/blood-2019-122521

Published: 2019

Journal Articles

Reducing Unnecessary Coagulation Testing in Outpatients (REDUCTION): A Quality Improvement Project

Fatima Khadadah, MBBS, Aziz Jiwajee, Hina Chaudhry, BSc, Paula D. James, MD, Rosane Nisenbaum, PhD, Rajesh Girdhari, MD, Curtis Handford, MD, Jonathan Hunchuck, Michelle Sholzberg, MDM, MSc, FRCPC

Blood (2018) 132 (Supplement 1): 4703.

https://doi.org/10.1182/blood-2018-99-113694

Published: 2018

Journal Articles

Bleeding Patterns in Type I VWD in Effect of VWF Levels: An Individual Participant Data Meta-Analysis of Three Cohorts

Alberto Tosetto, Pamela A Christopherson, Jeroen C.J. Eikenboom, MD, Julie Grabell, CCRP, Paula D. James, MD, Robert R Montgomery, MD, Ian Peake, PhD, Mariana Silva, MD FRCPC, Zimmerman Program Investigators

Blood (2018) 132 (Supplement 1): 1180.

https://doi.org/10.1182/blood-2018-99-115728

Published: 2018

Journal Articles

Prospective Diagnosis of VWD in a Large Cohort of Patients with Bleeding Symptoms through the Zimmerman Program

Veronica H Flood, MD, Pamela A Christopherson, Joan Cox Gill, MD, Kenneth Dale Friedman, MD, Sandra L Haberichter, PhD, Jorge Di Paola, MD, Paula D. James, MD, Janna M. Journeycake, MD, Steven R. Lentz, MD PhD, Cindy A. Leissinger, MD, Margaret V. Ragni, MD MPH, Madhvi Rajpurkar, MD, Jonathan C. Roberts, MD, Amy Shapiro, Robert F. Sidonio, Robert R Montgomery, MD, Thomas C. Abshire, MD

Blood (2018) 132 (Supplement 1): 979.

https://doi.org/10.1182/blood-2018-99-110650

Published: 2018

Journal Articles

Contribution of Select ISTH-BAT Subscores to the Total Score in Type 1 VWD

Jessica Garcia, MD, Pamela A Christopherson, Veronica H Flood, MD, Joan Cox Gill, MD, Robert R. Montgomery, MD, Paula D. James, MD, Pippa Simpson, PhD, Liyun Zhang, MS, Thomas C. Abshire, MD, Zimmerman Program Investigators

Blood (2017) 130 (Supplement 1): 1075.

https://doi.org/10.1182/blood.V130.Suppl_1.1075.1075

Published: 2017

Journal Articles

Validation of the Modified Self-Administered Pediatric Bleeding Assessment Questionnaire (Self-PBQ) in Children Aged 8-12 Years

Jessica Bui, BHSc, David Martyres, Paula D. James, MD, Julie Grabell, CCRP, John K. Wu, MBBS, FRCPC, MS, MacGregor Steele, MD FRCP(C), Mariana Silva, MD FRCPC, Margaret L. Rand, PhD, Victor S. Blanchette, MD, Robert J Klaassen, MD FRCPC

Blood (2017) 130 (Supplement 1): 2135.

https://doi.org/10.1182/blood.V130.Suppl_1.2135.2135

Published: 2017

Journal Articles

Does Age Affect Desmopressin Responsiveness in Patients with Von Willebrand Disease?

Nicola Goldberg, MD, Rosane Nisenbaum, PhD, Hong Song, David Lillicrap, MD FRCPC, Jerome M. Teitel, MD FRCPC, Paula D. James, MD, Michelle Sholzberg, MDM, MSc, FRCPC

Blood (2017) 130 (Supplement 1): 3681.

https://doi.org/10.1182/blood.V130.Suppl_1.3681.3681

Published: 2017

Journal Articles

Use of Bleeding Assessment Tools in the Diagnosis of Von Willebrand Disease: Are We Asking the Right Questions?

Jordan Spradbrow, BSc, Sasha Letourneau, Julie Grabell, CCRP, Yupu Liang, PhD, James Riddel, RN, MS, CPNP, Wilma Hopman, MSc, Victor S. Blanchette, MD, Margaret L. Rand, PhD, Barry S. Coller, MD, Andrew D. Paterson, MD, Paula D. James, MD

Blood (2017) 130 (Supplement 1): 2369.

https://doi.org/10.1182/blood.V130.Suppl_1.2369.2369

Published: 2017

Journal Articles

Novel Insights into the Clinical Phenotype and Pathophysiology Underlying Low VWF Levels: The Low Von Willebrand Factor in Ireland Cohort (LoVIC) Study

Michelle Lavin, MB FRCPath, Sonia Aguila, PhD, Sonja Schneppenheim, MD, Niall Dalton, BSc, Jamie M O'Sullivan, PhD, Niamh M O'Connell, MB, FRCPath, PhD, Kevin M. Ryan, MB, Mary Byrne, MSc, Margaret Nolan, BSc, Roger Preston, PhD, Ulrich Budde, MD, Paula D. James, MD, Jorge Di Paola, MD, James S O'Donnell, MD PhD

Blood (2016) 128 (22): 873.

https://doi.org/10.1182/blood.V128.22.873.873

Published: 2016

Journal Articles

Let's Talk Period: Preliminary Results of an Online Bleeding Awareness Knowledge Translation Project and Bleeding Assessment Tool Promoted on Social Media

Emily A Reynen, MDM, PharmD, Julie Grabell, BA, CCRP, Paula D. James, MD

Blood (2016) 128 (22): 3775.

https://doi.org/10.1182/blood.V128.22.3775.3775

Published: 2016

Journal Articles

Characterization of Bleeding in Hemophilia Carriers and Comparison to Women with Type 1 Von Willebrand Disease, Type 3 Von Willebrand Disease Obligate Carriers and Controls

Natasha Amrita Satkunam, MBBS, MSc, Johnny Mahlangu, MD, Christoph Bidlingmaier, MD PD, Dr. MD, Maria Eva Mingot-Castellano, PhD, Meera B. Chitlur, MD, Patrick F. Fogarty, MD, Adam Cuker, MD MS, Maria Elisa Mancuso, MD PhD, Pal André Holme, PhD MD, Julie Grabell, BA, CCRP, Wilma Hopman, MA, Prasad Mathew, MD, Paula D. James, MD

Blood (2016) 128 (22): 875.

https://doi.org/10.1182/blood.V128.22.875.875

Published: 2016

Journal Articles

Interim Canadian Data from a Prospective, Observational Study of Routine Clinical Use of a Von Willebrand Factor Concentrate (Wilate®)

Lidia Cosentino, PhD, Paula D. James, MD, Michelle Sholzberg, MDM, MSc, Alfonso Iorio, MD PhD

Blood (2016) 128 (22): 2593.

https://doi.org/10.1182/blood.V128.22.2593.2593

Published: 2016

Journal Articles

Testing for Heparin Induced Thrombocytopenia: Comparison of Practice at an Academic Center with Choosing Wisely Guidelines

DiMaria C Erica, MD, Alex Trussler, MD, Dyba Janique, MD, David Lee, MD FRCPC, Michael J. Rauh, MD PhD, Paula D. James, MD FRCPC, Wilma Hopman, MA, Annette E Hay, MB ChB

Blood (2015) 126 (23): 3469.

https://doi.org/10.1182/blood.V126.23.3469.3469

Published: 2015

Journal Articles

Heterogeneity Of Type 3 Von Willebrand Disease (VWD): Evidence From Patient-Derived Blood Outgrowth Endothelial Cells (BOEC)

Mackenzie L. Bowman, MSc, Lara J. Casey, Lindsey G. Hawke, Paula D. James, MD

Blood (2013) 122 (21): 3517.

https://doi.org/10.1182/blood.V122.21.3517.3517

Published: 2013

Journal Articles

Regulation Of Factor VIII Clearance By Mannose-Binding Lectins

Laura L. Swystun, PhD, Colleen Notley, Kate Sponagle, Paula D. James, MD, David Lillicrap

Blood (2013) 122 (21): 2340.

https://doi.org/10.1182/blood.V122.21.2340.2340

Published: 2013

Journal Articles

Normal Range Of Bleeding Scores For The ISTH-BAT: Adult and Pediatric Data From The Merging Project

Malak Elbatarny, Shamim Mollah, Julie Grabell, Margaret L. Rand, PhD, Dewi S. Clark, BSc, Andreas Mauer, Pamela A. Christopherson, Robert R. Montgomery, MD, Zimmerman Program Investigators, Barry S. Coller, MD, Paula D. James, MD

Blood (2013) 122 (21): 1107.

https://doi.org/10.1182/blood.V122.21.1107.1107

Published: 2013

Journal Articles

Characterization Of Von Willebrand Factor Splice Variants From Exonic & Intronic Splicing Mutations

Lindsey G. Hawke, Georges-Etienne Rivard, MD, Man-Chiu Poon, MD, Paula D. James, MD

Blood (2013) 122 (21): 1069.

https://doi.org/10.1182/blood.V122.21.1069.1069

Published: 2013

Journal Articles

The Endothelial Lectin Receptor CLEC4M Internalizes Factor VIII and Von Willebrand Factor Via a Clathrin-Coated Pit-Dependent Mechanism

Laura L. Swystun, PhD, Colleen Notley, Ilinca Georgescu, Paula D. James, MD, David Lillicrap, MD

Blood (2013) 122 (21): 1091.

https://doi.org/10.1182/blood.V122.21.1091.1091

Published: 2013

Journal Articles

Genetic Variability of the CLEC4M Endothelial Lectin Receptor Modulates Binding and Internalization of Von Willebrand Factor and Contributes to Variance in Plasma VWF Levels

Laura L. Swystun, PhD, Natalia Rydz, MD, Colleen Notley, Jonathan J. Riches, Andrew D Paterson, MD, Robert R. Montgomery, MD, Paula D. James, MD, David Lillicrap, MD

Blood (2012) 120 (21): 16.

https://doi.org/10.1182/blood.V120.21.16.16

Published: 2012

Journal Articles

Comparative Cellular Studies of the VWF Exon 4–5 Deletion Mutation Using Patient-Derived Blood Outgrowth Endothelial Cells (BOEC) and Megakaryocytes

Mackenzie L Bowman, MSc, Ling Li, MD, Fred Pluthero, PhD, Hilary Christensen, Irwin Walker, MBBS, Walter H. Kahr, MD, PhD, Paula D. James, MD

Blood (2012) 120 (21): 1076.

https://doi.org/10.1182/blood.V120.21.1076.1076

Published: 2012

NARROW

Take Control. Period. - Needs Assessment Leading to the Development of a Digital Quality Improvement Intervention Designed to Enhance Adherence to Tranexamic Acid and Iron Supplementation in Women with Heavy Menstrual Bleeding

Reducing Unnecessary Coagulation Testing in Outpatients (REDUCTION): A Quality Improvement Project

Bleeding Patterns in Type I VWD in Effect of VWF Levels: An Individual Participant Data Meta-Analysis of Three Cohorts

Prospective Diagnosis of VWD in a Large Cohort of Patients with Bleeding Symptoms through the Zimmerman Program

Contribution of Select ISTH-BAT Subscores to the Total Score in Type 1 VWD

Validation of the Modified Self-Administered Pediatric Bleeding Assessment Questionnaire (Self-PBQ) in Children Aged 8-12 Years

Does Age Affect Desmopressin Responsiveness in Patients with Von Willebrand Disease?

Use of Bleeding Assessment Tools in the Diagnosis of Von Willebrand Disease: Are We Asking the Right Questions?

Novel Insights into the Clinical Phenotype and Pathophysiology Underlying Low VWF Levels: The Low Von Willebrand Factor in Ireland Cohort (LoVIC) Study

Let's Talk Period: Preliminary Results of an Online Bleeding Awareness Knowledge Translation Project and Bleeding Assessment Tool Promoted on Social Media

Characterization of Bleeding in Hemophilia Carriers and Comparison to Women with Type 1 Von Willebrand Disease, Type 3 Von Willebrand Disease Obligate Carriers and Controls

Interim Canadian Data from a Prospective, Observational Study of Routine Clinical Use of a Von Willebrand Factor Concentrate (Wilate®)

Testing for Heparin Induced Thrombocytopenia: Comparison of Practice at an Academic Center with Choosing Wisely Guidelines

Heterogeneity Of Type 3 Von Willebrand Disease (VWD): Evidence From Patient-Derived Blood Outgrowth Endothelial Cells (BOEC)

Regulation Of Factor VIII Clearance By Mannose-Binding Lectins

Normal Range Of Bleeding Scores For The ISTH-BAT: Adult and Pediatric Data From The Merging Project

Characterization Of Von Willebrand Factor Splice Variants From Exonic & Intronic Splicing Mutations

The Endothelial Lectin Receptor CLEC4M Internalizes Factor VIII and Von Willebrand Factor Via a Clathrin-Coated Pit-Dependent Mechanism

Genetic Variability of the CLEC4M Endothelial Lectin Receptor Modulates Binding and Internalization of Von Willebrand Factor and Contributes to Variance in Plasma VWF Levels

Comparative Cellular Studies of the VWF Exon 4–5 Deletion Mutation Using Patient-Derived Blood Outgrowth Endothelial Cells (BOEC) and Megakaryocytes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only